Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001104659-18-041289

Chief Financial Officer bought 31,000 shares at an average $3.10 ($96,080)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Pizzie Nick Chief Financial Officer 2018-06-19 Purchase +400 $3.05 $1,220 400 D
Pizzie Nick Chief Financial Officer 2018-06-19 Purchase +30,600 $3.10 $94,860 31,000 D
Open-market purchases · 31,000 sh · avg $3.10 · $96,080
Loading xslF345X03/a4.xml…